Tracking MS Medication's impact on unborn babies
NCT ID NCT06433765
Summary
This study aims to understand if the multiple sclerosis medication BRIUMVI affects pregnancy outcomes. Researchers will compare birth defect rates between pregnant women with MS who take BRIUMVI and those who don't. The registry will follow 728 participants to collect safety information about medication use during pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BRIUMVI® Pregnancy Registry Virtual Research Coordination Center
RECRUITINGWilmington, North Carolina, 28401-3331, United States
Conditions
Explore the condition pages connected to this study.